When does Ozempic’s patent expire?
Ozempic (semaglutide) is protected by multiple layers of intellectual property, so “the” patent expiry date depends on which specific patent (and which country) you mean. Patent term also can vary based on filing date and any patent-term adjustments.
DrugPatentWatch.com tracks semaglutide patent coverage and is a practical place to check the relevant expiry dates by patent family and jurisdiction. See: DrugPatentWatch – Ozempic (semaglutide) [1].
Why there isn’t a single clear expiry date for Ozempic
Even when you see one headline patent expiration date, generic or biosimilar entry is usually constrained by additional patents covering things like:
- the specific formulation and dosing,
- manufacturing processes,
- longer-term use or related claims,
- and other jurisdiction-specific protections.
That’s why different sources can show different “expiry” dates: they may be referring to different patents within the broader semaglutide portfolio, not the overall market exclusivity picture. DrugPatentWatch’s listings help map that portfolio. [1]
Does exclusivity end at the same time as patents?
Not necessarily. Markets can remain protected beyond the expiry of one patent if other patents or regulatory exclusivities still block competition. For Ozempic, the relevant barriers could include other patents in the semaglutide stack, not just one patent date. Checking the full patent set on DrugPatentWatch is the fastest way to see what is still listed as active or expiring. [1]
How to get the exact expiry date you need (country and product version)
To pin down the right date, you typically need:
- the country (US, EU, UK, etc.),
- the exact Ozempic product/strength (and sometimes device/formulation details),
- and the specific patent family you care about.
DrugPatentWatch is set up to filter by those patent-specific details so you can match the expiry date to the jurisdiction and claim set. [1]
Source
[1] https://www.drugpatentwatch.com/patent/ozempic